Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Research article

Anti-angiogenic effect of the total flavonoids in Scutellaria barbata D. Don

Authors: Zhi-Jun Dai, Wang-Feng Lu, Jie Gao, Hua-Feng Kang, Yu-Guang Ma, Shu-Qun Zhang, Yan Diao, Shuai Lin, Xi-Jing Wang, Wen-Ying Wu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

Angiogenesis is closely related to the growth, invasion and metastasis of tumors, also considered as the key target of anticancer therapy. Scutellaria barbata D. Don (S. barbata), a traditional Chinese medicine, is being used to treat various diseases, including cancer. However, the antitumor molecular mechanism of S. barbata was still unclear. This study aimed to investigate the inhibitory effects of the total flavones in S. barbata (TF-SB) on angiogenesis.

Methods

Human umbilical vein endothelial cells (HUVECs) were treated with various concentrations of TF-SB. Cell viability was examined using the MTT assay. The scratch assay was used to detect the migration of HUVECs after treatment with TF-SB. The ability of HUVECs to form network structures in vitro was demonstrated using the tube formation assay. The chick embryo chorioallantoic membrane assay was performed to detect the in vivo anti-angiogenic effect. The expression of VEGF was measured by the enzyme-linked immunosorbent.

Results

Results showed that TF-SB inhibited the proliferation and migration of HUVECs in a dose- dependent manner. Simultaneously, TF-SB significantly suppressed HUVEC angiogenesis in vitro and in vivo. Furthermore, VEGF was downregulated in both HUVECs and MHCC97-H cells after TF-SB treatment.

Conclusion

TF-SB could suppress the process of angiogenesis in vitro and in vivo. TF-SB potentially suppresses angiogenesis in HUVECs by regulating VEGF. These findings suggested that TF-SB may serve as a potent anti-angiogenic agent.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed
2.
go back to reference Kim DY, Han KH: How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage. Dig Dis. 2012, 30: 598-602. 10.1159/000343088.CrossRef Kim DY, Han KH: How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage. Dig Dis. 2012, 30: 598-602. 10.1159/000343088.CrossRef
3.
go back to reference Chang CY, Huang ZN, Yu HH, Chang LH, Li SL, Chen YP, Lee KY, Chuu JJ: The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells. J Ethnopharmacol. 2008, 118: 387-395. 10.1016/j.jep.2008.05.001.CrossRefPubMed Chang CY, Huang ZN, Yu HH, Chang LH, Li SL, Chen YP, Lee KY, Chuu JJ: The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells. J Ethnopharmacol. 2008, 118: 387-395. 10.1016/j.jep.2008.05.001.CrossRefPubMed
4.
go back to reference Xu W, Towers AD, Li P, Collet JP: Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care. 2006, 15: 397-403. 10.1111/j.1365-2354.2006.00685.x.CrossRef Xu W, Towers AD, Li P, Collet JP: Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care. 2006, 15: 397-403. 10.1111/j.1365-2354.2006.00685.x.CrossRef
5.
go back to reference Normile D: The new face of traditional Chinese medicine. Science. 2003, 299: 188-190. 10.1126/science.299.5604.188.CrossRefPubMed Normile D: The new face of traditional Chinese medicine. Science. 2003, 299: 188-190. 10.1126/science.299.5604.188.CrossRefPubMed
6.
7.
go back to reference Mineo M, Garfield SH, Taverna S, Flugy A, DeLeo G, Alessandro R, Kohn EC: Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis. 2012, 15: 33-45. 10.1007/s10456-011-9241-1.CrossRefPubMed Mineo M, Garfield SH, Taverna S, Flugy A, DeLeo G, Alessandro R, Kohn EC: Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis. 2012, 15: 33-45. 10.1007/s10456-011-9241-1.CrossRefPubMed
8.
9.
go back to reference Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature. 2000, 407: 249-257. 10.1038/35025220.CrossRefPubMed Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature. 2000, 407: 249-257. 10.1038/35025220.CrossRefPubMed
10.
go back to reference Belting M, Ahamed J, Ruf W: Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscl Throm Vas. 2005, 25: 1545-1550. 10.1161/01.ATV.0000171155.05809.bf.CrossRef Belting M, Ahamed J, Ruf W: Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscl Throm Vas. 2005, 25: 1545-1550. 10.1161/01.ATV.0000171155.05809.bf.CrossRef
11.
go back to reference Wojtukiewicz MZ, Sierko E, Rak J: Contribution of the hemostatic system to angiogenesis in cancer. Semin Thromb Hemost. 2004, 30: 5-20.CrossRefPubMed Wojtukiewicz MZ, Sierko E, Rak J: Contribution of the hemostatic system to angiogenesis in cancer. Semin Thromb Hemost. 2004, 30: 5-20.CrossRefPubMed
12.
go back to reference Li JL, Sainson RCA, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL: Delta-like 4 notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth In vivo. Cancer Res. 2007, 67: 11244-11253. 10.1158/0008-5472.CAN-07-0969.CrossRefPubMed Li JL, Sainson RCA, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL: Delta-like 4 notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth In vivo. Cancer Res. 2007, 67: 11244-11253. 10.1158/0008-5472.CAN-07-0969.CrossRefPubMed
13.
go back to reference Roodink I, Leenders WPJ: Targeted therapies of cancer angiogenesis inhibition seems not enough. Cancer Lett. 2010, 299: 1-10. 10.1016/j.canlet.2010.09.004.CrossRefPubMed Roodink I, Leenders WPJ: Targeted therapies of cancer angiogenesis inhibition seems not enough. Cancer Lett. 2010, 299: 1-10. 10.1016/j.canlet.2010.09.004.CrossRefPubMed
14.
go back to reference Kim KW, Jin UH, Kim DI, Lee TK, Kim MS, Oh MJ, Kim MS, Kwon DY, Lee YC, Kim CH: Antiproliferative effect of Scutellaria barbata D. Don. on cultured human uterine leiomyoma cells by down-regulation of the expression of Bcl-2 protein. Phytother Res. 2008, 22: 583-590. 10.1002/ptr.1996.CrossRefPubMed Kim KW, Jin UH, Kim DI, Lee TK, Kim MS, Oh MJ, Kim MS, Kwon DY, Lee YC, Kim CH: Antiproliferative effect of Scutellaria barbata D. Don. on cultured human uterine leiomyoma cells by down-regulation of the expression of Bcl-2 protein. Phytother Res. 2008, 22: 583-590. 10.1002/ptr.1996.CrossRefPubMed
15.
go back to reference Tang PM, Chan JY, Zhang DM, Au SWN, Fong WP, Kong SK, Tsui SKW, Waye MMY, Mak TCW, Fung KP: Pheophorbide a, an active component in Scutellaria barbata, reverses P-glycoprotein-mediated multidrug resistance on a human hepatoma cell line R-HepG2. Cancer Biol Ther. 2007, 6: 504-509. 10.4161/cbt.6.4.3814.CrossRefPubMed Tang PM, Chan JY, Zhang DM, Au SWN, Fong WP, Kong SK, Tsui SKW, Waye MMY, Mak TCW, Fung KP: Pheophorbide a, an active component in Scutellaria barbata, reverses P-glycoprotein-mediated multidrug resistance on a human hepatoma cell line R-HepG2. Cancer Biol Ther. 2007, 6: 504-509. 10.4161/cbt.6.4.3814.CrossRefPubMed
16.
go back to reference Goh D, Lee YH, Ong ES: Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem. 2005, 53: 8197-8204. 10.1021/jf051506+.CrossRefPubMed Goh D, Lee YH, Ong ES: Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem. 2005, 53: 8197-8204. 10.1021/jf051506+.CrossRefPubMed
17.
go back to reference Yin X, Zhou J, Jie C, Xing DM, Zhang Y: Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci. 2004, 75: 2233-2244. 10.1016/j.lfs.2004.05.015.CrossRefPubMed Yin X, Zhou J, Jie C, Xing DM, Zhang Y: Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci. 2004, 75: 2233-2244. 10.1016/j.lfs.2004.05.015.CrossRefPubMed
18.
go back to reference Suh SJ, Yoon JW, Lee TK, Jin UH, Kim SL, Kim MS, Kwon DY, Lee YC, Kim CH: Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytother Res. 2007, 21: 135-141. 10.1002/ptr.2010.CrossRefPubMed Suh SJ, Yoon JW, Lee TK, Jin UH, Kim SL, Kim MS, Kwon DY, Lee YC, Kim CH: Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytother Res. 2007, 21: 135-141. 10.1002/ptr.2010.CrossRefPubMed
19.
go back to reference Dai ZJ, Gao J, Li ZF, Ji ZZ, Kang HF, Guan HT, Diao Y, Wang BF, Wang XJ: In vitro and In vivo antitumor activity of Scutellaria barbate extract on murine liver cancer. Molecules. 2011, 16: 4389-4400. 10.3390/molecules16064389.CrossRefPubMed Dai ZJ, Gao J, Li ZF, Ji ZZ, Kang HF, Guan HT, Diao Y, Wang BF, Wang XJ: In vitro and In vivo antitumor activity of Scutellaria barbate extract on murine liver cancer. Molecules. 2011, 16: 4389-4400. 10.3390/molecules16064389.CrossRefPubMed
20.
go back to reference Yu JQ, Liu HB, Lei JC, Tan WJ, Hu XT, Zou GL: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res. 2007, 21: 817-822. 10.1002/ptr.2062.CrossRefPubMed Yu JQ, Liu HB, Lei JC, Tan WJ, Hu XT, Zou GL: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res. 2007, 21: 817-822. 10.1002/ptr.2062.CrossRefPubMed
21.
go back to reference Qu GW, Yue XD, Li GS, Yu QY, Dai SJ: Two new cytotoxic ent-clerodane diterpenoids from Scutellaria barbata. J Asian Nat Prod Res. 2010, 12: 859-864. 10.1080/10286020.2010.507546.CrossRefPubMed Qu GW, Yue XD, Li GS, Yu QY, Dai SJ: Two new cytotoxic ent-clerodane diterpenoids from Scutellaria barbata. J Asian Nat Prod Res. 2010, 12: 859-864. 10.1080/10286020.2010.507546.CrossRefPubMed
22.
go back to reference Dai SJ, Sun JY, Ren Y, Liu K, Shen L: Bioactive ent-clerodane diterpenoids from Scutellaria barbata. Planta Med. 2007, 73: 1217-1220. 10.1055/s-2007-990215.CrossRefPubMed Dai SJ, Sun JY, Ren Y, Liu K, Shen L: Bioactive ent-clerodane diterpenoids from Scutellaria barbata. Planta Med. 2007, 73: 1217-1220. 10.1055/s-2007-990215.CrossRefPubMed
23.
go back to reference Mi X, Zhu R: Simultaneous determination of 7 active ingredients in Scutellaria barbata D. Don by capillary micellar electrokinetic chromatography. Se Pu. 2010, 28: 209-214.PubMed Mi X, Zhu R: Simultaneous determination of 7 active ingredients in Scutellaria barbata D. Don by capillary micellar electrokinetic chromatography. Se Pu. 2010, 28: 209-214.PubMed
24.
go back to reference Dai SJ, Peng WB, Shen L, Zhang DW, Ren Y: New norditerpenoid alkaloids from Scutellaria barbata with cytotoxic activities. Nat Prod Res. 2011, 15: 1-6. Dai SJ, Peng WB, Shen L, Zhang DW, Ren Y: New norditerpenoid alkaloids from Scutellaria barbata with cytotoxic activities. Nat Prod Res. 2011, 15: 1-6.
25.
go back to reference Wang XL, Zhang N, Huo Q, Yang Q: Anti-angiogenic and antitumor activities of Huaier aqueous extract. Oncol Rep. 2012, 28: 1167-1175.PubMedPubMedCentral Wang XL, Zhang N, Huo Q, Yang Q: Anti-angiogenic and antitumor activities of Huaier aqueous extract. Oncol Rep. 2012, 28: 1167-1175.PubMedPubMedCentral
26.
go back to reference Yeh JC, Cindrova-Davies T, Belleri M, Morbidelli L, Miller N, Cho CW, Chan K, Wang YT, Luo GA, Ziche M, Presta M, Charnock-Jones DS, Fan TP: The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis. 2011, 14: 187-197. 10.1007/s10456-011-9202-8.CrossRefPubMed Yeh JC, Cindrova-Davies T, Belleri M, Morbidelli L, Miller N, Cho CW, Chan K, Wang YT, Luo GA, Ziche M, Presta M, Charnock-Jones DS, Fan TP: The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis. 2011, 14: 187-197. 10.1007/s10456-011-9202-8.CrossRefPubMed
28.
go back to reference Borges J, Tegtmeier FT, Padron NT, Mueller MC, Lang EM, Stark GB: Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng. 2003, 9: 441-450. 10.1089/107632703322066624.CrossRefPubMed Borges J, Tegtmeier FT, Padron NT, Mueller MC, Lang EM, Stark GB: Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng. 2003, 9: 441-450. 10.1089/107632703322066624.CrossRefPubMed
29.
go back to reference Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A: VEGF coordinates interaction of pericytes and endothelial cells during vasculogen-esis and experimental angiogenesis. Dev Dyn. 2004, 230: 23-33. 10.1002/dvdy.20020.CrossRefPubMed Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A: VEGF coordinates interaction of pericytes and endothelial cells during vasculogen-esis and experimental angiogenesis. Dev Dyn. 2004, 230: 23-33. 10.1002/dvdy.20020.CrossRefPubMed
30.
go back to reference Kilarski WW, Petersson L, Fuchs PF, Zielinski MS, Gerwins P: An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels. Angiogenesis. 2012, 15: 643-655.PubMedPubMedCentral Kilarski WW, Petersson L, Fuchs PF, Zielinski MS, Gerwins P: An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels. Angiogenesis. 2012, 15: 643-655.PubMedPubMedCentral
31.
go back to reference Yu JL, Rak JW: Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res. 2003, 5: 83-88. 10.1186/bcr573.CrossRefPubMedPubMedCentral Yu JL, Rak JW: Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res. 2003, 5: 83-88. 10.1186/bcr573.CrossRefPubMedPubMedCentral
32.
go back to reference Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999, 77: 527-543. 10.1007/s001099900019.CrossRefPubMed Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999, 77: 527-543. 10.1007/s001099900019.CrossRefPubMed
33.
go back to reference Delli-Carpini J, Karam AK, Montgomery L: Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis. 2010, 13: 43-58. 10.1007/s10456-010-9163-3.CrossRefPubMed Delli-Carpini J, Karam AK, Montgomery L: Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis. 2010, 13: 43-58. 10.1007/s10456-010-9163-3.CrossRefPubMed
34.
go back to reference Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK, Firestone GL: BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Bio Ther. 2010, 10: 397-405. 10.4161/cbt.10.4.12424.CrossRef Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK, Firestone GL: BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Bio Ther. 2010, 10: 397-405. 10.4161/cbt.10.4.12424.CrossRef
35.
go back to reference Shiau AL, Shen YT, Hsieh JL, Wu CL, Lee CH: Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 α in lung tumor. Environ Toxicol. 2012, 10.1002/tox.21763. Shiau AL, Shen YT, Hsieh JL, Wu CL, Lee CH: Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 α in lung tumor. Environ Toxicol. 2012, 10.1002/tox.21763.
36.
go back to reference Wei LH, Lin JM, Xu W, Hong ZF, Liu XX, Peng J: Inhibition of tumor angiogenesis by Scutellaria barbata D. Don via suppressing proliferation, migration and tube formation of endothelial cells and downregulation of the expression of VEGF-A in cancer cells. J Med Plants Res. 2011, 5: 3260-3268. Wei LH, Lin JM, Xu W, Hong ZF, Liu XX, Peng J: Inhibition of tumor angiogenesis by Scutellaria barbata D. Don via suppressing proliferation, migration and tube formation of endothelial cells and downregulation of the expression of VEGF-A in cancer cells. J Med Plants Res. 2011, 5: 3260-3268.
37.
go back to reference Lee TK, Kim DI, Song YL, Lee YC, Kim HM, Kim CH: Differential inhibition of Scutellaria barbata D. Don (Lamiaceae) on HCG-promoted proliferation of cultured uterine leiomyomal and myometrial smooth muscle cells. Immunopharmacol Immunotoxicol. 2004, 26: 329-342. 10.1081/IPH-200026841.CrossRefPubMed Lee TK, Kim DI, Song YL, Lee YC, Kim HM, Kim CH: Differential inhibition of Scutellaria barbata D. Don (Lamiaceae) on HCG-promoted proliferation of cultured uterine leiomyomal and myometrial smooth muscle cells. Immunopharmacol Immunotoxicol. 2004, 26: 329-342. 10.1081/IPH-200026841.CrossRefPubMed
38.
go back to reference Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, Hung MC, Kuo ML: The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell. 2006, 9: 209-223. 10.1016/j.ccr.2006.02.018.CrossRefPubMed Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, Hung MC, Kuo ML: The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell. 2006, 9: 209-223. 10.1016/j.ccr.2006.02.018.CrossRefPubMed
39.
go back to reference Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL: A phase IB dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat. 2010, 120: 111-118. 10.1007/s10549-009-0678-5.CrossRefPubMed Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL: A phase IB dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat. 2010, 120: 111-118. 10.1007/s10549-009-0678-5.CrossRefPubMed
40.
go back to reference Wei LH, Lin JM, Xu W, Cai Q, Shen A, Hong Z, Peng J: Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of hedgehog pathway in a mouse model of colorectal cancer. Int J Mol Sci. 2012, 13: 9419-9430. 10.3390/ijms13089419.CrossRefPubMedPubMedCentral Wei LH, Lin JM, Xu W, Cai Q, Shen A, Hong Z, Peng J: Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of hedgehog pathway in a mouse model of colorectal cancer. Int J Mol Sci. 2012, 13: 9419-9430. 10.3390/ijms13089419.CrossRefPubMedPubMedCentral
41.
go back to reference Viana CT, Campos PP, Carvalho LA, Cenedezi JM, Lavall L, Lopes MT, Ferreira MA, Andrade SP: Distinct types of tumors exhibit differential grade of inflammation and angiogenesis in mice. Microvasc Res. 2012, 86: 44-51.CrossRefPubMed Viana CT, Campos PP, Carvalho LA, Cenedezi JM, Lavall L, Lopes MT, Ferreira MA, Andrade SP: Distinct types of tumors exhibit differential grade of inflammation and angiogenesis in mice. Microvasc Res. 2012, 86: 44-51.CrossRefPubMed
42.
go back to reference Ono M: Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008, 99: 1501-1506. 10.1111/j.1349-7006.2008.00853.x.CrossRefPubMed Ono M: Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008, 99: 1501-1506. 10.1111/j.1349-7006.2008.00853.x.CrossRefPubMed
43.
go back to reference Mantovani A, Schioppa T, Porta C, Allavena P, Sica A: Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metast Rev. 2006, 25: 315-322. 10.1007/s10555-006-9001-7.CrossRef Mantovani A, Schioppa T, Porta C, Allavena P, Sica A: Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metast Rev. 2006, 25: 315-322. 10.1007/s10555-006-9001-7.CrossRef
44.
go back to reference Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR: Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol. 2001, 159: 651-659. 10.1016/S0002-9440(10)61736-1.CrossRefPubMedPubMedCentral Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR: Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol. 2001, 159: 651-659. 10.1016/S0002-9440(10)61736-1.CrossRefPubMedPubMedCentral
Metadata
Title
Anti-angiogenic effect of the total flavonoids in Scutellaria barbata D. Don
Authors
Zhi-Jun Dai
Wang-Feng Lu
Jie Gao
Hua-Feng Kang
Yu-Guang Ma
Shu-Qun Zhang
Yan Diao
Shuai Lin
Xi-Jing Wang
Wen-Ying Wu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-150

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue